About Hytanbio-Tech.
Hong Kong business development. Shaoxing manufacturing roots. A project-focused approach to OEM and ODM.
Research and manufacturing background
Hytanbio-Tech was founded in Hong Kong in 2026 as a biological research and development entity supporting international business expansion. Its in-house commercial manufacturing base was established in 2014 in Shaoxing, Mainland China. According to the company profile, the research center covers more than 4,000 square meters and supports multiple peptide production lines with large-scale synthesizers, analytical and preparative HPLC systems, and laboratories built to GMP standards. The company reports an ISO 9001:2015 quality management system. Its core portfolio includes cosmetic-grade peptide raw materials, lyophilized peptide powder, dissolvable microneedle patches and dissolvable oral films. These company capabilities provide context for project discussions; they do not by themselves establish the performance or market authorization of an injection pen. Device-specific evidence is reviewed against the exact proposed configuration and application.
From feasibility to a defined project
The company’s stated service model connects formulation feasibility, prototype sampling, specification confirmation, batch documentation and export coordination. It serves skincare brands, cosmetic laboratories, beauty institutions and cross-border distributors with cosmetic-oriented development and manufacturing support. This website provides a dedicated entry point for injection pen OEM and ODM project inquiries. The initial discussion clarifies the intended application, technical requirements and responsibilities before a scope is proposed. Cosmetic-grade materials are not represented as injectable-grade medicines, and company-level quality credentials are not presented as universal medical device approvals. For an injection device program, buyers should request the applicable documentation for the responsible entity, manufacturing site and device configuration. Our team uses the project brief to identify what is available, what needs development and which questions require further technical or regulatory review.
Company-provided qualification overview
